Wenqin Yue, Guilin Tang, Meilan Liu, Cheng He, Jing Ding, T Wang, J M Wang, Xiaoxia Hu, W P Zhang, L Chen, Jianyu Yang
Abstract
CD123 widely expressed in AML patients, which was an independent risk factor for CR1 and OS, which implicating its important role in evaluating the induction chemotherapy response and prognosis of AML.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
CD123 widely expressed in AML patients, which was an independent risk factor for CR1 and OS, which implicating its important role in evaluating the induction chemotherapy response and prognosis of AML.
Key concepts: Interleukin-3 receptor, Medicine, Myeloid leukemia, Bone marrow, Flow cytometry, Leukemia, Internal medicine, Myeloid